Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
0
Story being shared
CureLab taps Aldevron to manufacture cancer vaccine
Aldevron agreed to manufacture CureLab Oncology's DNA-based therapeutic cancer vaccine for use in clinical trials in Russia and the U.S. CureLab said the vaccine showed strong antitumor responses in animal models of breast and lung cancer.
Or we can send an email on your behalf